CRVS
Corvus Pharmaceuticals Inc
11.80$
-5.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.7% | -17.9% | -8.7% | +0.0% | -4.8% | +10.0% | +31.8% | -3.4% | -7.1% | +11.5% | +17.2% | – | |
| – | +4.8% | +20.5% | +11.5% | -8.7% | +20.5% | +48.0% | +0.4% | -0.6% | +26.0% | +68.4% | -1.5% | – | |
| – | – | – | -348.9% | – | -547.5% | – | +1,803.3% | -119.0% | – | -94.7% | -4,596.5% | – | |
| – | – | – | – | – | – | – | +213.9% | -100.0% | – | +264.0% | +539.6% | – | |
| – | -113.2% | -99.7% | +249,957.1% | -77.8% | +56.4% | – | -578.5% | -87.1% | – | -1,431.3% | -95.9% | – | |
| – | -100.0% | – | – | -99.8% | +37,116.0% | -98.5% | +12,720.8% | -99.0% | -94.4% | +953,630.0% | -99.9% | – | |
| – | -160.1% | – | – | -237.6% | – | -192.1% | – | -222.0% | – | +1,978.8% | -159.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.